Is the NOD mouse a good model for type 1 diabetes?

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• The Non-Obese Diabetic (NOD) mouse is a widely used model for studying type 1 diabetes (T1D).
• Understanding the NOD mouse model is crucial for advancing T1D research and therapeutic development.
• This review provides a historical perspective on the NOD mouse model's contributions to T1D research.

Purpose of the Study:

• To review the historical progress in understanding the etiology and immune pathogenesis of type 1 diabetes using the NOD mouse model.
• To highlight the utility of the NOD mouse model in shaping the landscape of immunotherapeutics for T1D.
• To discuss the application and limitations of the NOD mouse model in T1D research and drug development.

Main Methods:

• Historical review of scientific literature concerning the NOD mouse model and type 1 diabetes.
• Analysis of research findings on genetics, beta cell stress, innate and adaptive immunity, and autoantigens in NOD mice.
• Examination of immunotherapeutic agents tested in both NOD mice and human clinical trials.

Main Results:

• The NOD mouse model has significantly advanced the understanding of T1D etiology and immune pathogenesis.
• Non-antigen-specific immunotherapies have shown more consistent success in NOD mice and humans compared to antigen-specific therapies.
• There are inherent differences between mouse models and human T1D, necessitating appropriate use and interpretation of data.

Conclusions:

• The NOD mouse remains an important resource for T1D research, despite limitations.
• Effective utilization of the NOD mouse model requires appropriate comparisons and realistic expectations.
• Further research should focus on optimizing the use of the NOD mouse and other models to maximize knowledge gain in T1D.